Nonsurgical management of Peyronie’s disease
- 5 November 2018
- journal article
- review article
- Published by Springer Nature in Nature Reviews Urology
- Vol. 16 (3) , 172-186
Abstract
Peyronie’s disease is not a rare disorder, and it can be devastating to the affected man. Although the gold-standard treatment of Peyronie’s disease is surgery in the stable phase, nonoperative management is preferred by some men and is the only treatment option in the acute phase of the disease, when surgery is contraindicated. No oral or topical therapy has been shown to be efficacious when administered alone, but some evidence supports their use as part of a combination therapy regimen. Intralesional therapies, particularly collagenase clostridium histolyticum (CCH), have shown promise. Mechanical therapies can provide benefit when applied for prolonged periods of time, improving penile curvature, indentation, and even restoring length. Regardless of the modality chosen, patient counselling is paramount, as recovery of the penis to its predisease state is highly unlikely. Thus, although many options exist for nonsurgical management of Peyronie’s disease, surgery remains the best option for men who desire the most reliable and rapid pathway to a functionally straight, erect penis. The goal of nonsurgical therapy should be a scientifically feasible, safe approach to prevent the progression of, or reduce, deformity and improve sexual function.Keywords
This publication has 122 references indexed in Scilit:
- The association between Peyronie's and Dupuytren's diseaseInternational Journal Of Impotence Research, 2011
- Pentoxifylline treatment and penile calcifications in men with Peyronie's diseaseAsian Journal of Andrology, 2010
- Prevalence, Incidence, and Treatments of Dupuytren's Disease in the United States: Results from a Population-Based StudyHAND, 2010
- Pentoxifylline Attenuates Transforming Growth Factor-β1-Stimulated Collagen Deposition and Elastogenesis in Human Tunica Albuginea-Derived Fibroblasts Part 1: Impact on Extracellular MatrixThe Journal of Sexual Medicine, 2010
- Use of Penile Extender Device in the Treatment of Penile Curvature as a Result of Peyronie’s Disease. Results of a Phase II Prospective StudyThe Journal of Sexual Medicine, 2009
- Effects of long‐term vardenafil treatment on the development of fibrotic plaques in a rat model of Peyronie's diseaseBJU International, 2006
- Risk factors for Peyronie's disease: a case‐control studyBJU International, 2006
- Expanding the paradigm for plaque development in Peyronie's diseaseInternational Journal Of Impotence Research, 2003
- Clinical presentations of Peyronie's diseaseInternational Journal Of Impotence Research, 2002
- Peyronie's disease in men under age 40: characteristics and outcomeInternational Journal Of Impotence Research, 2001